Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousBone MarrowHematopoietic Stem CellsGraft vs Host DiseaseBone Marrow CellsTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationHematologic NeoplasmsTissue DonorsTransplantation ChimeraLeukemiaGraft SurvivalPeripheral Blood Stem Cell TransplantationHistocompatibility TestingBone and BonesStem CellsTreatment OutcomeAnemia, AplasticBusulfanHistocompatibilityHematopoiesisAntineoplastic Combined Chemotherapy ProtocolsRecurrenceCombined Modality TherapyLiver TransplantationCyclophosphamideImmunosuppressive AgentsLeukemia, Myeloid, AcuteRetrospective StudiesTime FactorsKidney TransplantationMice, Inbred C57BLTransplantation, IsogeneicHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow PurgingCord Blood Stem Cell TransplantationRemission InductionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntigens, CD34Hematologic DiseasesCytomegalovirus InfectionsSurvival AnalysisHLA AntigensBone Marrow DiseasesCell DifferentiationHematopoietic Stem Cell MobilizationMyelodysplastic SyndromesGraft RejectionSurvival RateImmunosuppressionGraft vs Leukemia EffectDisease-Free SurvivalMyeloablative AgonistsColony-Forming Units AssayAcute DiseaseTransplantation ImmunologyChimerismMultiple MyelomaLymphocyte DepletionSevere Combined ImmunodeficiencyLymphocyte TransfusionLymphoma, Non-HodgkinRadiation ChimeraFlow CytometryT-LymphocytesLeukemia, MyeloidOpportunistic InfectionsGraft vs Tumor EffectBone Marrow ExaminationFollow-Up StudiesImmunocompromised HostCyclosporineGranulocyte Colony-Stimulating FactorMelphalanCell LineageMesenchymal Stem Cell TransplantationHeart TransplantationCell TransplantationAntilymphocyte SerumFatal OutcomeCells, CulturedBone RemodelingPrognosisSiblingsBone Marrow NeoplasmsSalvage TherapyLung TransplantationCell SeparationHodgkin DiseaseCytarabineOrgan TransplantationInfectionNuclear FamilyLeukocyte TransfusionCytomegalovirus